Classement en actions
#17840
Neovasc Inc. is a medical technology firm specializing in the design,... Neovasc Inc. is a medical technology firm specializing in the design, production, and global distribution of cardiovascular devices, particularly across European markets and beyond. Its primary offerings include the Tiara system, developed for the transcatheter treatment of mitral valve disease, and the Neovasc Reducer, used to address chronic, debilitating chest pain known as refractory angina. Established in 2000, the company, which maintains its headquarters in Richmond, Canada, was formerly named Medical Ventures Corp. before adopting its current identity, Neovasc Inc., in July 2008.
Prix de l'action
$29.82
Dernière synchronisation: 2023-04-11
Capitalisation boursière
$223.68M
Changement (1 jour)
1.21%
Échange Neovasc Inc. (NVCN)
Le prix NVCN avec la capitalisation boursière de B
Capitalisation boursière de Neovasc Inc.(NVCN)
Capitalisation boursière: $223.68M
En September 2026, Neovasc Inc. a une capitalisation boursière de $223.68M. Cela fait de Neovasc Inc. la 17840th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Neovasc Inc. du 2001 au 2026
NVCN par rapport au top 5 des plus populaires stocks
| Prix pour NVCN |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.424T
|
+2,424,906.63%
|
|
|
|
|
$4.776T
|
+2,135,027.86%
|
|
|
|
|
$4.052T
|
+1,811,320.46%
|
|
|
|
|
$3.691T
|
+1,650,030.99%
|
|
|
|
|
$2.744T
|
+1,226,752.87%
|
